We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,231
Increased
3,688
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CIK
7126
Credit Suisse Asset Management Income Fund
CIK
$133M
$25.7K ﹤0.01%
8,643
COOK icon
7127
Traeger
COOK
$170M
$25.7K ﹤0.01%
214
-521
-71% -$60.2K
IDX icon
7128
VanEck Indonesia Index ETF
IDX
$36.5M
$25.5K ﹤0.01%
1,611
+733
+83% +$11.7K
DTRE icon
7129
First Trust Alerian Disruptive Technology Real Estate ETF
DTRE
$14.6M
$25.4K ﹤0.01%
664
+395
+147% +$15.2K
GTBP icon
7130
GT Biopharma
GTBP
$11.1M
$25.4K ﹤0.01%
8,981
+7,958
+778% +$28.5K
CNTA
7131
DELISTED
Centessa Pharmaceuticals
CNTA
$25.4K ﹤0.01%
2,809
+931
+50% +$8.83K
OPER icon
7132
ClearShares Ultra-Short Maturity ETF
OPER
$105M
$25.3K ﹤0.01%
253
+46
+22% +$4.62K
GYRE icon
7133
Gyre Therapeutics
GYRE
$726M
$25.3K ﹤0.01%
+2,123
New +$29.1K
GDXJ icon
7134
PUT
VanEck Junior Gold Miners ETF
GDXJ
$7.79B
$25.3K ﹤0.01%
600
TPCS icon
7135
TechPrecision Corp
TPCS
$46.9M
$25.1K ﹤0.01%
7,331
+6,627
+941% +$27.7K
ELA icon
7136
Envela
ELA
$466M
$25.1K ﹤0.01%
5,598
-4,226
-43% -$19.3K
FRAF icon
7137
Franklin Financial Services
FRAF
$281M
$25.1K ﹤0.01%
888
+56
+7% +$1.54K
MOLN
7138
Molecular Partners
MOLN
$152M
$25K ﹤0.01%
3,461
+3,135
+962% +$14.7K
BBBI icon
7139
BondBloxx BBB Rated 5-10 Year Corporate Bond ETF
BBBI
$170M
$24.9K ﹤0.01%
+500
New +$24.8K
CRML icon
7140
Critical Metals Corp
CRML
$972M
$24.9K ﹤0.01%
2,212
-20,801
-90% -$219K
ELVA
7141
Electrovaya
ELVA
$457M
$24.9K ﹤0.01%
+9,656
New +$29.3K
PQDI
7142
Principal Spectrum Preferred and Income ETF
PQDI
$70.3M
$24.9K ﹤0.01%
1,329
+1,285
+2,920% +$23.9K
STNC icon
7143
Hennessy Sustainable ETF
STNC
$93.6M
$24.9K ﹤0.01%
846
-5,062
-86% -$148K
BKF icon
7144
iShares MSCI BIC ETF
BKF
$78.1M
$24.9K ﹤0.01%
+693
New +$24.7K
XYLG icon
7145
Global X S&P 500 Covered Call & Growth ETF
XYLG
$65.5M
$24.8K ﹤0.01%
806
+25
+3% +$751
WNW icon
7146
Meiwu Technology Co
WNW
$73.2M
$24.7K ﹤0.01%
+14
New +$28.9K
GWH icon
7147
ESS Tech
GWH
$19.6M
$24.7K ﹤0.01%
2,015
-4,104
-67% -$46.2K
SEPT icon
7148
AllianzIM U.S. Equity Buffer10 Sep ETF
SEPT
$33.4M
$24.7K ﹤0.01%
+850
New +$24K
IVOL icon
7149
Quadratic Interest Rate Volatility and Inflation Hedge ETF
IVOL
$272M
$24.7K ﹤0.01%
1,334
-4,526
-77% -$83.9K
NE.WS.A icon
7150
Noble Corporation PLC Tranche 2 Warrants
NE.WS.A
$24.7K ﹤0.01%
1,141
+67
+6% +$1.55K

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.